Hyundai Bioscience top holder CnPharm cuts shares under pledge contracts to 7.76% from 7.92%
Bitget2026/09/30 08:04- CnPharm filed an amended large-shareholding report for Hyundai Bioscience, citing changes to stock-pledge contracts.
- Total stake held steady at 11,546,001 shares, or 11.96%, as of Sept. 30.
- Voting rights also remained unchanged at 9,746,797 votes, or 10.10%.
- Shares subject to major contracts fell to 7,486,806 shares, or 7.76%, from 7,641,806 shares, or 7.92%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of England hawkish official: Growth exceeds expectations and employment is resilient, which precisely proves that further rate hikes are necessary.
Megan Greene, a policymaker at the Bank of England, stated that the UK's economic growth surpassing expectations and the resilience of the job market indicate that the Bank of England's efforts to curb inflation are still insufficient.
24 Hour Crypto Recap: Here’s What Happened in the Market
AI investment is reshaping the bond market! Sunak: By 2027, the net issuance of long-term bonds by technology companies may surpass that of the US government
By 2027, tech companies are expected to become larger net issuers of long-term debt than the U.S. government.
Crypto prices
More
